CVS Health Change in Accounts Receivable 2010-2025 | CVS

CVS Health annual/quarterly change in accounts receivable history and growth rate from 2010 to 2025. Change in accounts receivable can be defined as the increase or decrease in accounts receivable for the given period.
  • CVS Health change in accounts receivable for the quarter ending June 30, 2025 was $-3.053B, a 201.5% decline year-over-year.
  • CVS Health change in accounts receivable for the twelve months ending June 30, 2025 was $-2.542B, a 68.13% decline year-over-year.
  • CVS Health annual change in accounts receivable for 2024 was $-1.301B, a 79.22% decline from 2023.
  • CVS Health annual change in accounts receivable for 2023 was $-6.26B, a 110.7% increase from 2022.
  • CVS Health annual change in accounts receivable for 2022 was $-2.971B, a 9.91% increase from 2021.
CVS Health Annual Change in Accounts Receivable
(Millions of US $)
2024 $-1,301
2023 $-6,260
2022 $-2,971
2021 $-2,703
2020 $-1,510
2019 $-2,158
2018 $-1,139
2017 $-941
2016 $-243
2015 $-1,594
2014 $-737
2013 $-2,210
2012 $-387
2011 $-748
2010 $532
2009 $-86
Sector Industry Market Cap Revenue
Medical Medical Services $83.126B $372.809B
CVS Health Corporation is a pharmacy innovation company. Its offerings include pharmacy benefit management services, mail order, retail and specialty pharmacy, disease management programs, and retail clinics. The Company serves employers, insurance companies, unions, government employee groups, managed care organizations and other sponsors of health benefit plans, and individuals under the CVS Caremark Pharmacy Services, Caremark, CVS Caremark, CarePlus CVS/pharmacy, RxAmerica, Accordant, SilverScript, and Novologix names. CVS Health Corporation, formerly known as CVS Caremark Corporation, is headquartered in Woonsocket, Rhode Island.
Stock Name Country Market Cap PE Ratio
Danaher (DHR) United States $143.611B 26.64
Elevance Health (ELV) United States $66.200B 8.90
Cencora (COR) United States $55.265B 18.41
DiDi Global (DIDIY) China $26.074B 27.70
Labcorp Holdings (LH) United States $22.092B 17.56
Natera (NTRA) United States $20.748B 0.00
BioMerieux (BMXMF) France $17.652B 0.00
EUROFINS SCIENT (ERFSF) Luxembourg $14.860B 0.00
CochLear (CHEOY) Australia $13.234B 0.00
ICON (ICLR) Ireland $12.795B 12.31
Solventum (SOLV) United States $12.697B 13.13
Medpace Holdings (MEDP) United States $12.202B 32.29
Viatris (VTRS) United States $11.385B 4.02
Revvity (RVTY) United States $10.080B 17.76
Sonic Healthcare (SKHHY) Australia $8.961B 0.00
HealthEquity (HQY) United States $8.047B 35.25
Avantor (AVTR) United States $7.840B 11.50
Caris Life Sciences,�Inc (CAI) United States $7.569B 0.00
Charles River Laboratories (CRL) United States $7.320B 13.89
Bausch + Lomb (BLCO) Canada $4.828B 32.48
Sotera Health (SHC) United States $3.965B 22.17
Amplifon S.p.A (AMFPF) Italy $3.937B 21.83
BrightSpring Health Services (BTSG) United States $3.681B 28.08
Surgery Partners (SGRY) United States $3.031B 38.13
GeneDx Holdings (WGS) United States $3.020B 69.16
Alignment Healthcare (ALHC) United States $2.873B 0.00
Concentras Parent (CON) United States $2.771B 17.58
Organon (OGN) United States $2.397B 2.61
Progyny (PGNY) United States $1.959B 41.54
Premier (PINC) United States $1.921B 14.58
Ardent Health (ARDT) United States $1.702B 6.57
PACS (PACS) United States $1.698B 0.00
Pediatrix Medical (MD) United States $1.248B 8.33
GoodRx Holdings (GDRX) United States $1.239B 20.41
Teladoc Health (TDOC) United States $1.230B 0.00
Establishment Labs Holdings (ESTA) $1.008B 0.00
Ryman Healthcare (RYHTY) New Zealand $0.970B 0.00
Embecta (EMBC) United States $0.718B 4.21
AMN Healthcare Services Inc (AMN) United States $0.660B 8.17
CareDx (CDNA) United States $0.637B 11.73
Performant Healthcare (PHLT) United States $0.602B 0.00
QDM (QDMI) Hong Kong, SAR China $0.586B 201.00
So-Young (SY) China $0.506B 0.00
Omada Health (OMDA) $0.490B 0.00
Nutex Health (NUTX) United States $0.488B 7.39
Auna S.A (AUNA) Luxembourg $0.460B 10.37
Sonida Senior Living (SNDA) United States $0.460B 0.00
SBC Medicals (SBC) United States $0.456B 0.00
InnovAge Holding (INNV) United States $0.447B 0.00
COMPASS Pathways (CMPS) United Kingdom $0.421B 0.00
Enhabit (EHAB) United States $0.386B 25.40
Oncology Institute (TOI) United States $0.382B 0.00
Agilon Health (AGL) United States $0.362B 0.00
LifeMD (LFMD) United States $0.323B 0.00
Beauty Health (SKIN) United States $0.238B 0.00
Shoulder Innovations (SI) $0.189B 0.00
DocGo (DCGO) United States $0.160B 0.00
Ascend Wellness Holdings (AAWH) United States $0.106B 0.00
Sera Prognostics (SERA) United States $0.093B 0.00
KindlyMD (NAKA) United States $0.073B 0.00
NeueHealth (NEUE) United States $0.061B 0.00
Biodesix (BDSX) United States $0.059B 0.00
IceCure Medical (ICCM) Israel $0.048B 0.00
Basel Medical Group (BMGL) Singapore $0.038B 0.00
NeuroOne Medical Technologies (NMTC) United States $0.037B 0.00
ModivCare (MODV) United States $0.035B 0.00
OSR Holdings (OSRH) United States $0.012B 0.00
Intelligent Bio Solutions (INBS) United States $0.011B 0.00
BioNexus Gene Lab (BGLC) $0.010B 0.00
SeaStar Medical Holding (ICU) United States $0.009B 0.00
Co-Diagnostics (CODX) United States $0.009B 0.00
XWELL (XWEL) United States $0.007B 0.00
Pheton Holdings (PTHL) China $0.006B 0.00
Aclarion (ACON) United States $0.004B 0.00
ISpecimen (ISPC) United States $0.003B 0.00
NewGenIvf Group (NIVF) Thailand $0.002B 0.00
INVO Fertility (IVF) United States $0.001B 0.00
Cano Health (CANOQ) United States $0.000B 0.00